Arzeda Raising $12 Million


Arzeda, a University of Washington spinout that designs custom-built enzymes, is raising $12 million in Series A funding, according to Xconomy. OVP Venture Partners and WRF Capital have already signed onto the deal, which is expected to close in April.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.